Thyroid function alterations following quetiapine initiation in a developmentally disabled adolescent [5]

Annals of Pharmacotherapy

Volumn 38, Issue 9, 2004, Pages 1541-1542

  Dobbs, Richard L ^a   Brahm, Nancy C ^a   Fast, Gary ^b   Brown, Robert C ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b Dept of Devmtl Disabil Services ^*

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; DESMOPRESSIN; FLUOXETINE; GABAPENTIN; LIOTHYRONINE; LITHIUM CARBONATE; METHYLPHENIDATE; PAROXETINE; QUETIAPINE; THYROTROPIN; THYROXINE; TRAZODONE; ZIPRASIDONE;

ADOLESCENCE; ADULT; BIPOLAR DISORDER; BORDERLINE STATE; CASE REPORT; CONDUCT DISORDER; DEVELOPMENTAL DISORDER; DISABILITY; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPOTHYROIDISM; LETTER; LIOTHYRONINE BLOOD LEVEL; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; NEUROGENIC DIABETES INSIPIDUS; ONSET AGE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOAFFECTIVE PSYCHOSIS; THYROID DISEASE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; HUMANS; HYPOTHYROIDISM; MALE; MENTAL DISORDERS; MENTAL RETARDATION; THYROID FUNCTION TESTS;

EID: 4143086939     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E054     Document Type: Letter

References (4)

1. Bendz H, Aurell M. Drug-induced diabetes insipidus: incidence, prevention and management. Drug Saf 1999;21:449-56.
2. Feret BM, Caley CF. Possible hypothyroidism associated with quetiapine. Ann Pharmacother 2000;34:483-6. DOI 10.1345/aph.l9186
3. Shaw JA, Lewis JE, Pascal S, Sharma RK, Rodriguez RA, Guillen R, et al. A study of quetiapine: efficacy and tolerability in psychotic adolescents. J Child Adolesc Psychopharmacol 2001;11:415-24.
4. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.